Mirae Asset Nifty 500 Healthcare ETF

A Equity ETF scheme from Mirae Asset Mutual Fund. Figures below are for the Regular · option not stated plan (ISIN INF769K01QA6).

NAV ₹22.4528 on 16 November 2026.

Expense ratio

Total expense ratio 0.35% a year for the Regular · option not stated plan, as AMFI published it on 29 October 2026: base expense ratio 0.16%, brokerage 0.01%, transaction costs 0.00%, statutory levies including GST 0.18%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino

Too little NAV history for the 1, 3, 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 100.0% of the portfolio.

  1. Sun Pharmaceutical Industries Limited — 9.77%
  2. Divi's Laboratories Limited — 9.08%
  3. Laurus Labs Limited — 6.85%
  4. Apollo Hospitals Enterprise Limited — 6.35%
  5. Dr. Reddy's Laboratories Limited — 6.03%
  6. Cipla Limited — 5.67%
  7. Torrent Pharmaceuticals Limited — 4.96%
  8. Max Healthcare Institute Limited — 4.68%
  9. Lupin Limited — 3.57%
  10. Aurobindo Pharma Limited — 3.40%

Plans

Other funds in Equity ETF

All 86 funds in Equity ETF · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.